Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP
Nihar R. Desai, MD, MPH
Potassium Binders to Optimize GDMT Therapy in HFrEF
Ellie Kelepouris, MD, FACP, FAHA
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
Pauline A. Swift, PhD
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Jonathan Barratt, MD, PhD
An De Vriese, MD, PhD
Decoding IgA Nephropathy: From Suspicion to Solution
Chee Kay Cheung, MBChB, MRCP, PhD
Jörg Latus, MD
Translating Evidence into IgAN Care
The Future of IgAN Care
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Winning the CKD-aP Battle: A United Physician-Nurse Front
Reading Between the Lines: What PROMs Reveal About Itch
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.